# Multiple Ascending-Dose Study to Evaluate the Safety, Tolerability and Pharmacokinetics of BMS-933043 in Healthy Subjects

> **NCT01605994** · PHASE1 · COMPLETED · sponsor: **Bristol-Myers Squibb** · enrollment: 115 (actual)

## Conditions studied

- Healthy Adult Normals

## Interventions

- **DRUG:** BMS-933043
- **DRUG:** Placebo matching with BMS-933043
- **DRUG:** Antacid Buffer Predose Solution

## Key facts

- **NCT ID:** NCT01605994
- **Lead sponsor:** Bristol-Myers Squibb
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-07
- **Primary completion:** 2013-12
- **Final completion:** 2013-12
- **Target enrollment:** 115 (ACTUAL)
- **Last updated:** 2014-06-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01605994

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01605994, "Multiple Ascending-Dose Study to Evaluate the Safety, Tolerability and Pharmacokinetics of BMS-933043 in Healthy Subjects". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT01605994. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*